VG Life Sciences Competitors and Similar CompaniesClear all
Epizyme's competitors and similar companies include Outlook Therapeutics and Oncolytics Biotech.
 Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. |  Outlook Therapeutics Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. |  Oncolytics Biotech Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies. | |
Founding Date | Founding Date 2007 | Founding Date 2011 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Woodbridge Township, US HQ | Locations Calgary, CA HQ Calgary, CA San Diego, US |
Employees | Employees 20364% increase | Employees 1726% decrease | Employees 28 |
Valuation ($) | Valuation ($) 250.8 m | Valuation ($) 136.5 m | Valuation ($) 93.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) $37.4m (FY, 2021) | Revenue (est.) $1.4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $10.5m (FY, 2021) | Cost of goods $1.4m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $57.2k (FY, 2025) | Gross profit N/A |
Net income | Net income ($251.1m) (FY, 2021) | Net income ($62.4m) (FY, 2025) | Net income ($28.8m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 51.5m | Total funding raised N/A | Total funding raised $ 24m |
For sources of this data, please see the company profile
View Company Profiles
Outlook Therapeutics
HQ
Woodbridge Township, US
Employees
17↓ 26% decrease
Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics.
View companyOncolytics Biotech
HQ
Calgary, CA
Employees
28
Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies.
View company